SRSenija Rasić

Senija Rasić

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Senija Rasić has a total of 41 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Synergism of Malnutrition, Inflammation and Fluid Load in the Development of Atherogenesis in Uremic Patients Undergoing Peritoneal Dialysis

    by Damir Rebic, Senija Rasic, Velma Rebic, Vedad Herenda

    Objective: Approximately 50% of end stage renal disease (ESRD) patients lose their lives as a consequence of cardiovascular diseases due to accelerated atherosclerosis. The objectives of this study were to investigate the synergistic effect between nutritional status, inflammation and volume load with atherogenesis estimated using structural and hemodynamic changes in the carotid arteries (CA) in patients on peritoneal dialysis (PD). Methods: Prospective longitudinal study. The study sample consisted of 50 ESRD patients who were treated with PD and were observed for an 18 months after the commencement of dialysis treatment. All examined patients underwent 4 to 5 dialysis changes with 2 liters of dialysis solution. The laboratory findings were complemented with ultrasound of CA and echocardiography at baseline and at the end of follow-up. Results: C-reactive protein (CRP), B-type natriuretic peptide and homocysteine significantly were significantly decreased, while normal protein nitrogen appearance (nPNA) and albumin values were significantly increased after 18 months on PD. The carotid intima-media thickness (CIMT), left atrium diameter was significantly decreased (pConclusion: We have found a close relationship between hemodynamic and structural CA changes with markers of poor nutrition, inflammation and hydration status in PD patients. The synergism of atherogenesis and monitored parameters, especially CA diameter and CIMT, seems to be useful in the management of PD patients and deserves further testing in properly designed clinical validation study.

    • 14 August 2015
      • p. 1-7

    Valvular calcification and left ventricular modifying in peritoneal dialysis patients.

    by Damir Rebić, Senija Rašić, Aida Hamzić-Mehmedbašić, Jasminka Džemidžić, Emir Kurtalić

    Cardiac valve calcification (CVC) and left ventricular (LV) alterations are frequent complication in end-stage renal disease (ESRD). We determined the prevalence of CVC and LV hypertrophy (LVH) in ESRD patients before renal replacement therapy and 12 months after peritoneal dialysis (PD). A prospective longitudinal of 50 incident PD patients was studied. Demographic and clinical data were recorded and blood assayed at baseline and after 1-year of follow-up. CVC and LVH were evaluated by M-mode two-dimensional echocardiography. CVC of the mitral and aortic valves and of both valves were noted in 30, 18 and 10% of patients, respectively. After 12 months of PD regimen, 20% patients had aortic, 24% mitral and 8% had calcification of both valves. After one year of PD, LVH was 62 and 36% in patients with and without CVC, respectively (p < 0.05). Endothelin-1 is an independent predictor of CVC at the baseline, while nitric oxide is inversely an independent predictor at the end of follow-up. CVC is associated with LVH in PD patients. These findings identified a potential role for monitored markers to be incorporated into therapeutic strategies aimed at detection and treatment of cardiovascular complications and prevention strategies.


  • Open Access

    Influence of Malondialdehyde and Matrix Metalloproteinase‐9 on Progression of Carotid Atherosclerosis in Chronic Renal Disease with Cardiometabolic Syndrome

    by Senija Rašić, Damir Rebić, Sabaheta Hasić, Ismar Rašić, Marina Delić Šarac

    Objective was to assess whether the concentration of malondialdehyde (MDA) as a marker of lipid peroxidation and serum concentration of matrix metalloproteinase‐9 (MMP‐9) are involved in the process of atherosclerosis in chronic kidney disease (CKD) patients nondialysis‐dependent and those on peritoneal dialysis (PD), both with signs of cardiometabolic syndrome (CMS). Thirty CKD and 22 PD patients were included in a study. All observed patients were divided into three subgroups depending on the degree of atherosclerotic changes in the carotid arteries (CA). Severity of atherosclerotic changes in the CA was evaluated by ultrasonography. We confirmed significantly lower level of serum MDA throughout all the stages of atherosclerosis in PD patients compared with observed CKD patients (P < 0.05) and increased serum concentration of MDA and MMP‐9 with the progression of severity atherosclerotic changes in both groups of patients. The multiple regression analysis revealed that MDA and MMP‐9 are significant predictors of changes in IMT‐CA CKD patients (P < 0.05) and plaque score on CA in these patients (P < 0.05). The results suggest that MDA and MMP‐9 could be mediators of CKD‐related vascular remodeling in CMS.


  • Open Access

    Microscopic polyangiitis presented with polyneuropathy of lower extremities and ANCA-associated glomerulonephritis: Case Report

    by Senija Rašić, Jasminka Džemidžić, Zinaida Karasalihović, Vedad Herenda, Damir Rebić

    We present the case of a 67-year-old female patient with microscopic polyangiitis presented with polyneuropathy of lower extremities and rapidly progressive glomerulonephritis. Disease had started as a pain and weakening of muscular strength first in the left and than in the right leg. Electromiography has shown that a mainly dominant neurological affection was paresis of peroneal nerve in both lower extremities. In laboratory examination the titer of anti-myeloperoxidase anti-neutrophilic cytoplasmic antibodies (p-ANCA) was elevated. Due to renal involvement presented as a microscopic haematuria and decreasing of renal function, patient undergone kidney biopsy. It confirmed the immune vasculitis microscopic polyangiitis type with ANCA-associated glomerulonephritis. This is one of rare case of microscopic polyangiitis without lung simptomatology, first presented with asymmetrical polineuropathy of lower extremities. The patient was treated with methylprednisolone and cyclophosphamide in dosis adjusted to the level of disease severity and the renal function (methylprednisolone 1 mg/kg of body weight for two months with gradually tapering to the minimum effective dose and cyclophosphamide 1 mg/kg of body weight). This treatment lead to the partial remission of disease. In maintenance therapy azathioprin was introduced instead of cyclophosphamide.


  • Open Access

    Endothelial dysfunction in uremic patients on continuous ambulatory peritoneal dialysis (CAPD)

    by Senija Rašić, Almira Hadžović-Džuvo, Damir Rebić, Amina Valjevac, Snežana Unčanin

    Endothelial dysfunction is associated with diabetic micro- and macroangiopathy as well as with the decline in creatinine clearance. It has been suggested that endothelial dysfunction presents in patients (pts) on continuous ambulatory peritoneal dialysis (CAPD). The objective of this study was to examine the plasma biomarkers of endothelial dysfunction and their association with IMT of carotid arteries in diabetic and non-diabetic patients on CAPD. This study included 37 CAPD pts (25 with type II diabetes and 12 non-diabetic pts) mean age 59.2 years ± 2.48. Plasma von Willebrand factor (vWF) activity, serum albumin, glucose, total cholesterol, triglycerides and lipoprotein (a) levels, as well as serum level of homocysteine, parathyroid hormone (PTH) in plasma and microalbuminuria was determined. Ultrasound examination of carotid arteries was performed in all patients by measured bilateral intima-media thickness of carotid artery (CIMT). Mean IMT value was significantly higher in type 2 DM patients (0.86 ± 0.04 mm) compared to non-diabetic patients (0.52 ± 0.06 mm) on peritoneal dialysis (p<0.0001). There was also a significant difference in lipids/triglycerides and Lp (a)/, procoagulation (fibrinogen, von Wilebrand factor, factor VIII) and inflammatory markers (CRP) level between type 2 DM and non-diabetic CAPD patients. A stepwise multiple regression analysis revealed that log triglycerides and factor VIII were independent factors for the IMT. The results of this research impose that diabetic type 2 CAPD patients have developed systemic alteration of endothelial function and higher risk of cardiovascular complications compared to non-diabetic CAPD patients.


  • The Importance of Using Peritoneal Equlibration Test for the Peritoneal Transport Type Characterization in Continuous Ambulatory Peritoneal Dialysis Patients

    by Snežana Unčanin, Senija Rašić, Jasminka Džemidžić, Alma Muslimović, Begler Begović, Vedad Herenda

    The aim of this study was to analyze the importance of the peritoneal equilibration test (PET) in evaluation of the peritoneal membrane tranport status in patients treated with continuous ambulatory peritoneal dialysis (CAPD). The study included 30 adult continuous ambulatory peritoneal dialysis (CAPD) patients, 16 male and 14 female, mean age 61 ± 16,5 years with a prescription of four exchanges of 2 litres (L) per day, who underwent peritoneal equilibration test (PET). Eleven of patients were diabetics. A modified PET was performed during a 4 hours dwell using 4,25% glucose dialysis solution. The dialysate/plasma ratio of creatinine (D/P) at the end of the procedure, and the dialysate 240 min/initial dialysate ratio of glucose (D/D0) were calculated and used as parametar of solute transport. With the test, chategorisation of patients was possible into high (H), high-average (HA), low average (LA), and low (L) transporters. In multivariate analysis age, gender, time on dialysis, comorbid diseases, diabetes mellitus (DM), serum albumin, were concidered as independent factors influencing the PET. Among 30 patients 5 (16,7%) were classified as H transpoters, 6 (20%) as HA, and 19 (63,3%) as LA. There were no patients in low category. Creatinine D/P at 4 hours was not different DM and non-DM patients. There were significant differences in gender, comorbid disease, serum albumin, D4/D0 glucose and volume drained in 4 hours. The high transporter group had higher proporsion of man (p<0,05), higher proportion of patients with comorbid diseases, lower serum albumin concentration (p<0,001), lower D4/D0 glucose (p<0,001), and lower drained volume (p<0,001). The PET was en easy, inexpensive, reliable test to assess peritoneal transport type and it also provided information about peritoneal clearance of solutes and ultrafiltration. Peritoneal transport type classification was recognized not only as aid for prescription, but also as a prognostic index.

    • 1 December 2009
      • p. 141-4

    Impact of hemoglobin concentration on plasma B-type natriuretic peptide level and left ventricle echocardiographics characteristics in chronic kidney disease patients.

    by Senija Rasić, Almira Hadzović-Dzuvo, Monika Tomić, Snjezana Uncanin, Slavica Corić

    Anemia is common in patients with chronic kidney disease (CKD) and contributes to cardiovascular alterations. Recent findings suggest that B-type natriuretic peptide (BNP) is a sensitive biomarker for left ventricular dysfunction, but relationship between hemoglobin and BNP in CKD patients is unclear. Hemoglobin, plasma BNP and serum creatinine levels were measured in 49 patients with CKD (without heart failure), divided in two groups according to the hemoglobin status (cut-off point 110 g/L). All patients underwent echocardiography in order to assess left ventricular (LV) morphology and function. The results showed that in the group of patients with hemoglobin levels under 110 g/L BNP levels were significantly elevated (p < 0.001), as well as left ventricular mass index (p < 0.001). Systolic and diastolic LV function were significantly better in patients with hemoglobin levels above 110 g/L (p < 0.001). Hemoglobin levels were inversely related to BNP values (r = -0.451, p < 0.001). Significantly negative correlation between BNP level and creatinine clearance (p = 0.009), and significantly positive correlation between BNP level and left ventricular mass index (LVMI) were established. A similar but positive relationship was observed between hemoglobin levels and creatinine clearance (p < 0.01). We established statistically significant negative correlation between hemoglobin levels and LVMI (r = -0.564, p < 0.001). In conclusion, BNP and hemoglobin levels depend on the renal function. Anemia may contribute to elevated BNP levels in CKD patients, and may represent an important confounder of the relationship between BNP and cardiac alteration in these patients.

    • 1 January 2009
      • Vol. 63  (2)

    Acute renal failure and ureteral leak after open surgery aortoiliac aneurysm repair.

    by Senija Rasic, Alden Prcic, Damir Rebic, Damir Aganovic, Nedzad Rustempasic, Vesna Sarajlic, Ismar Rasic

    We present a case of 52 year old male with an acute renal failure that took place 4 days after open transabdominal surgery repair of infrarenal abdominal aneurysm along with aneurysm of left common iliac artery and dilatation of left external iliac artery. Patient was subjected to 13 hemodialysis treatments that resulted in satisfactory recovery of renal function. One month after aneurysm repair he developed the right ureteral leak, consequently urinoma and acute renal failure once again. We suppose that ureteral leak was related to segmental ischemic necrosis of right ureter but not to traction or other iatrogenic ureteral injury. Percutaneous nephrostomy and insertion of ureteral stent was resulted in complete recovery of renal function.

    • 1 January 2009
      • Vol. 63  (4)

    [Immunosuppressive treatment of idiopathic membranous glomerulonephritis with nephrotic syndrome].

    by Alma Muslimović, Senija Rasić, Damir Rebić, Snezana Uncanin

    The effects of two immunosuppressive therapeutic protocols have been analyzed to evaluate the influence of treatments on the level of proteinuria, value of creatinine clearance and the level of serum albumin of patients with idiopathic membranous glomerulonephritis (IMGN) and nephrotic syndrome.

    • 1 January 2008
      • p. 7-11

    [Relationship between B-type natriuretic peptide plasma level and left ventricular function in patients with chronic kidney disease on different type of treatment].

    by Senija Rasić, Almira Hadzovic-Dzuvo, Damir Rebić, Jasminka Dzemidzić, Fatima Bilal, Amra Mataradzija

    To evaluate relationship between echocardiography finding of LV mass and function and B-type natriuretic peptide (BNP) plasma level in patients with chronic kidney disease on different type of treatment. We performed comparative examine on a parallel groups of kidney patients with no clinical signs of heart failure: 25 patients with chronic kidney disease (CKD, creatinine klirens < 60 ml/min), 25 patients on peritoneal dialysis (PD), 34 patients on hemodialysis (HD) and 22 renal transplant patients. Each patient underwent echocardiography investigations and measured plasma level B-type natriuretic peptide. It was determined that hemodialysis patients had higher value of left ventricular mass index (LVMI). The incidence of left ventricular hypertrophy (LVH) progressive increased from CKD patients to HD patients (78.6% vs. 88.9%), as well as a plasma level of B-type natriuretic peptide (174.2 vs. 1020.2 pg/ml). There was a significant positive correlation between LVMI and BNP plasma level in CKD (p = 0.008) and HD patients (p = 0.001), as well as significant negative correlation between BNP plasma level and LV diastolicfunction in CKD patients (p = 0.002). Plasma BNP concentration was elevated in renal dysfunction. Plasma BNP levels and the incidence of LVH were significantly grater in HD patients than in other renal patients. Significant positive correlation between plasma BNP level and LVMI suggested simultaneous influence of renal dysfunction and plasma BNP level on development of LV dysfunction.